Literature DB >> 23023562

Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.

Eleanor F Need1, Luke A Selth, Tiffany J Harris, Stephen N Birrell, Wayne D Tilley, Grant Buchanan.   

Abstract

The cellular response to circulating sex steroids is more than the sum of individual hormone actions, instead representing an interplay between activities of the evolutionarily related steroid hormone receptors. An example of this interaction is in breast cancer, where the risk of dying from estrogen receptor-α (ERα)-positive disease decreases approximately 4-fold when androgen receptor (AR) expression is high. In this study, we used chromatin immunoprecipitation sequencing (ChIP-seq) and microarray expression profiling to investigate the genomic and transcriptional cross talk between AR and ERα signaling in a luminal breast cancer cell line model, ZR-75-1. Expression profiling demonstrated reciprocal interference between 5α-dihydrotestosterone (DHT)- and 17β-estradiol (E(2))-induced transcriptional programs. Specifically, regulation of 26% of E(2) and 15% of DHT target genes was significantly affected by cotreatment with the other hormone, in the majority of cases (78-83%) antagonistically. Pathway analysis suggested that DHT cotreatment, for example, depleted E(2)-regulated pathways in cell survival and proliferation. ChIP-seq identified substantial overlap between the steroid receptor cistromes in ZR-75-1 cells, with 10-13% of AR- and ERα-binding sites located within 10 kb of the other receptor. Enrichment of androgen response elements in ERα-binding sites and vice versa was revealed by motif analysis, and AR-binding sites were enriched about E(2)-responsive genes affected by DHT cotreatment. Targeted ChIP and expression analysis revealed locus-specific outcomes when AR and ERα bind to the same DNA region. This work provides the first cistrome data for two steroid receptors in the same cell, insight into the antagonistic interplay between estrogens and androgens in luminal breast cancer, and an important resource for future work aimed at evaluating interrelated steroid receptors in different cellular systems.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023562      PMCID: PMC3487621          DOI: 10.1210/me.2011-1314

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  59 in total

1.  Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.

Authors:  Tze Howe Charn; Edison Tak-Bun Liu; Edmund C Chang; Yew Kok Lee; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2009-11-06

2.  Genomic antagonism between retinoic acid and estrogen signaling in breast cancer.

Authors:  Sujun Hua; Ralf Kittler; Kevin P White
Journal:  Cell       Date:  2009-06-26       Impact factor: 41.582

3.  Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs.

Authors:  Luigi Cicatiello; Margherita Mutarelli; Oli M V Grober; Ornella Paris; Lorenzo Ferraro; Maria Ravo; Roberta Tarallo; Shujun Luo; Gary P Schroth; Martin Seifert; Christian Zinser; Maria Luisa Chiusano; Alessandra Traini; Michele De Bortoli; Alessandro Weisz
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

4.  Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function.

Authors:  Anastasia Wyce; Yuchen Bai; Sunil Nagpal; Catherine C Thompson
Journal:  Mol Endocrinol       Date:  2010-07-07

5.  Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Kelly A Holmes; Dominic Schmidt; Christiana Spyrou; Roslin Russell; Charlie E Massie; Sarah L Vowler; Matthew Eldridge; Jason S Carroll
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

Review 6.  Androgens and the breast.

Authors:  Constantine Dimitrakakis; Carolyn Bondy
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

7.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.

Authors:  Amelia A Peters; Grant Buchanan; Carmela Ricciardelli; Tina Bianco-Miotto; Margaret M Centenera; Jonathan M Harris; Shalini Jindal; Davendra Segara; Li Jia; Nicole L Moore; Susan M Henshall; Stephen N Birrell; Gerhard A Coetzee; Robert L Sutherland; Lisa M Butler; Wayne D Tilley
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

8.  Chromatin interaction analysis using paired-end tag sequencing.

Authors:  Melissa J Fullwood; Yuyuan Han; Chia-Lin Wei; Xiaoan Ruan; Yijun Ruan
Journal:  Curr Protoc Mol Biol       Date:  2010-01

9.  Androgens induce divergent proliferative responses in human breast cancer cell lines.

Authors:  S N Birrell; J M Bentel; T E Hickey; C Ricciardelli; M A Weger; D J Horsfall; W D Tilley
Journal:  J Steroid Biochem Mol Biol       Date:  1995-05       Impact factor: 4.292

10.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.

Authors:  Jeremy Goecks; Anton Nekrutenko; James Taylor
Journal:  Genome Biol       Date:  2010-08-25       Impact factor: 13.583

View more
  38 in total

Review 1.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

2.  Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.

Authors:  Dan Dai; Qiao-Chu Li; Qiong-Bin Zhu; Shao-Hua Hu; Rawien Balesar; Dick Swaab; Ai-Min Bao
Journal:  Neuropsychopharmacology       Date:  2017-04-27       Impact factor: 7.853

3.  Alterations in replication timing of cancer-related genes in malignant human breast cancer cells.

Authors:  Andrew Fritz; Seema Sinha; Narasimharao Marella; Ronald Berezney
Journal:  J Cell Biochem       Date:  2013-05       Impact factor: 4.429

4.  Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.

Authors:  Yun Teng; Lacey M Litchfield; Margarita M Ivanova; Russell A Prough; Barbara J Clark; Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2014-05-17       Impact factor: 4.102

Review 5.  Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.

Authors:  Gerard A Tarulli; Geraldine Laven-Law; Reshma Shakya; Wayne D Tilley; Theresa E Hickey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-09-21       Impact factor: 2.673

Review 6.  Family Matters: Collaboration and Conflict Among the Steroid Receptors Raises a Need for Group Therapy.

Authors:  Matthew J Sikora
Journal:  Endocrinology       Date:  2016-11-11       Impact factor: 4.736

7.  Cooperative Dynamics of AR and ER Activity in Breast Cancer.

Authors:  Nicholas C D'Amato; Michael A Gordon; Beatrice Babbs; Nicole S Spoelstra; Kiel T Carson Butterfield; Kathleen C Torkko; Vernon T Phan; Valerie N Barton; Thomas J Rogers; Carol A Sartorius; Anthony Elias; Jason Gertz; Britta M Jacobsen; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2016-08-26       Impact factor: 5.852

8.  GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.

Authors:  Diana C West; Deng Pan; Eva Y Tonsing-Carter; Kyle M Hernandez; Charles F Pierce; Sarah C Styke; Kathleen R Bowie; Tzintzuni I Garcia; Masha Kocherginsky; Suzanne D Conzen
Journal:  Mol Cancer Res       Date:  2016-05-02       Impact factor: 5.852

Review 9.  Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers.

Authors:  Thu H Truong; Carol A Lange
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

10.  Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer.

Authors:  Neill Patani; Anita K Dunbier; Helen Anderson; Zara Ghazoui; Ricardo Ribas; Elizabeth Anderson; Qiong Gao; Roger A'hern; Alan Mackay; Justin Lindemann; Robert Wellings; Jill Walker; Irene Kuter; Lesley-Ann Martin; Mitch Dowsett
Journal:  Clin Cancer Res       Date:  2014-06-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.